XETRA · Technology
Invest in MeVis Medical Solutions stock from India
Indian and foreign residents can buy MeVis Medical Solutions (M3V) shares directly through Paasa.
By Paasa · Updated
MeVis Medical Solutions at a glance
- Price
- €23.00+€0.00 (0.00%)
- Market cap
- €41.86M
- Day range
- €23.00 – €23.00
- P/E
- 30.26
- Dividend yield
- 4.13%
- Volume
- 212.00
- 1 month
- -3.36%
- 6 months
- +0.88%
- YTD
- -6.50%
- 1 year
- -8.73%
- 5 years
- -29.45%
MeVis Medical Solutions statements, FY2021–FY2025
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | €16.1M | €17.0M | €17.3M | €18.8M | €16.2M |
| Gross profit | €15.7M | €16.5M | €7.0M | €18.0M | €15.8M |
| Operating income | €2.3M | €4.0M | €6.4M | €6.3M | €6.5M |
| Net income | €3.2M | €4.6M | €4.9M | €7.8M | €4.5M |
| Earnings per share | €1.74 | €2.51 | €2.70 | €4.28 | €2.50 |
| EBITDA | €3.4M | €4.8M | €5.2M | €8.0M | €4.8M |
| Total assets | €25.9M | €26.5M | €28.1M | €31.2M | €27.5M |
| Total debt | €0.0 | €0.0 | €0.0 | €0.0 | €0.0 |
| Cash and short-term investments | €6.5M | €6.5M | €7.7M | €9.3M | €7.6M |
| Shareholders' equity | €17.8M | €17.8M | €17.8M | €17.8M | €17.8M |
| Operating cash flow | €3.9M | €3.1M | €5.9M | €4.9M | €9.1M |
| Free cash flow | €3.7M | €2.8M | €5.8M | €4.7M | €9.1M |
| Capital expenditure | −€140.4K | −€301.9K | −€79.7K | −€133.1K | −€50.9K |
Fiscal years as reported, the latest ending 30 Sep 2025. Figures in EUR; a dash means the provider reported nothing for that line.
Peer comparison
| Company | Ticker | Price | Market cap |
|---|---|---|---|
| MPH Health Care | 93M1.DE | €26.00 | €111.32M |
| BRAIN Biotech | BNN.DE | €2.79 | €60.95M |
| H100 | GS9.F | €0.17 | €57.39M |
| DocCheck | AJ91.DE | €11.00 | €55.81M |
| aap Implantate | AAQ1.DE | €1.70 | €25.02M |
| NanoRepro | NN6.DE | €1.73 | €21.82M |
| Maternus-Kliniken | MAK.DE | €0.93 | €19.40M |
| Geratherm Medical | GME.DE | €2.31 | €12.50M |
Peers as grouped by the data provider. This is not an investment recommendation.
How to invest in MeVis Medical Solutions from India
Step 1
Open your Paasa account
KYC takes a few minutes: PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Step 2
Add funds from your Indian bank account
Remit up to $250,000 a year under the RBI's Liberalised Remittance Scheme. Your bank converts the rupees to US dollars at its rate on the day you remit, and Interactive Brokers converts the dollars to EUR when you buy.
Step 3
Search M3V and buy
Find MeVis Medical Solutions by name or by its ticker, M3V, and place your order.
Why invest in MeVis Medical Solutions from India
What MeVis Medical Solutions does
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. MeVis Medical Solutions operates in the Software - Application industry within the Technology sector.
Paasa handles the paperwork
Investing abroad brings paperwork with it: remittance filings, capital gains reporting, foreign asset disclosure. Paasa prepares all of it for you. Your India-ready tax reports arrive at year end, ready to file.
Frequently asked questions
Can I buy MeVis Medical Solutions stock from India?
Yes. Indian residents and NRIs can buy MeVis Medical Solutions (M3V) shares directly through Paasa. MeVis Medical Solutions is listed on XETRA, in the Software - Application industry. Your money leaves India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name at Interactive Brokers.
What tax do I pay in India when I sell MeVis Medical Solutions shares?
In India, gains on shares held for more than 24 months are long-term and taxed at 12.5%, and gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. Both are worked out in rupees at the EUR/INR rate on the day you bought and the day you sold, so the currency move is part of the gain. Paasa's capital-gains statement gives you the figures for your return.